223 (1)

12
Experimental Non-Inferiority Trial of Synthetic Small-calibre Biodegradable vs. Stable Vascular Grafts Departments of 1 Cardiovascular Surgery, 3 Pathology and 4 Radiology University Hospital of Geneva; Dept. of 2 Pharmaceutics & Biopharmaceutics EPGL, University of Geneva; Switzerland. 1 Beat H. WALPOTH, MD FAHA Damiano Mugnai 1 , Sarra de Valence 2 , Wojciech Mrowczynski 1 , Jean-Christophe Tille 3 , Xavier Montet 4 , Robert Gurny 2 , Michael Moeller 2 , Afksendiyos Kalango

description

Enveronmental

Transcript of 223 (1)

  • Experimental Non-Inferiority Trial of Synthetic Small-calibre Biodegradable vs. Stable Vascular GraftsDepartments of 1Cardiovascular Surgery, 3Pathology and 4Radiology University Hospital of Geneva; Dept. of 2Pharmaceutics & Biopharmaceutics EPGL, University of Geneva; Switzerland.1Beat H. WALPOTH, MD FAHA

    Damiano Mugnai1, Sarra de Valence2, Wojciech Mrowczynski1, Jean-Christophe Tille3, Xavier Montet4, Robert Gurny2, Michael Moeller2, Afksendiyos Kalangos1

  • OBJECTIVES: There is a big need for shelf-ready, synthetic, small calibre prostheses for cardiovascular revascularisation procedures. Biodegradable scaffolds resistant to degradation-induced aneurysm formation in the systemic arterial circulation have been developed for :

    in vivo vascular tissue-engineering

    Our aim is to assess the long-term results of synthetic, biodegradable, electrospun, small-calibre vascular grafts compared to ePTFE for aortic replacement in the rat model.

  • Vascular Tissue Engineering:Manufacturing of scaffoldsBiodegradable grafts (polycaprolactone = PCL) were produced by random nano-fibre electro-spinning (porosity 80%)Modern BARBAPAPA technique to create novel vascular grafts

  • METHODS - I: 14 anaesthetised Sprague Dawley rats (male, 275g), received an infrarenal aortic graft (8 biodegradable; 6 ePTFE) replacement (end-to-end; 2mm ID; 20mm long) and 6 rats (same age) served as sham (controls)PCL graftQuality and patency control after surgery with transit time flowmeter2 mmePTFE graft

  • METHODS - II: After 15 months survival in vivo high resolution ultra-sonography (Visualsonics) and angiography were performed to assess patency, stenosis, aneurysm formation, intimal hyperplasia and compliance. After explantation micro CT calcification quantification, histology, immuno-histology, scanning electron microscopy (SEM) and morphometry were carried out.

  • RESULTS:PCL vs. ePTFE grafts at 15 months

    PCL ( n=8)ePTFE (n=6)P